Concepedia

Maria Teresa Voso

MT

167

Publications

10.1K

Citations

55

H-Index

1992

Active since

Affiliations

University of Rome Tor Vergata(Current)

Università Cattolica del Sacro Cuore

Istituti di Ricovero e Cura a Carattere Scientifico

Sapienza University of Rome

Fondazione Santa Lucia

Maria Teresa Voso is an author at University of Rome Tor Vergata specializing in medicine, hematology, and cancer research.

ORCID

Top concepts

Publications per year

1992–2025

167

Publications

167

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 746 citations · Full text

, , +20

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 606 citations · Full text

, , +11

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Sergio Amadori, Stefan Suciu, Dominik Selleslag et al. · Journal of Clinical Oncology · 2016 · 341 citations · Full text

PU.1 (Spi-1) and C/EBPα Regulate Expression of the Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Gene

Stefan Hohaus, Martha Petrovick, Maria Teresa Voso et al. · Molecular and Cellular Biology · 1995 · 293 citations · Full text

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation

Matteo Giovanni Della Porta, Anna Gallì, Andrea Bacigalupo et al. · Journal of Clinical Oncology · 2016 · 251 citations · Full text

Rows per page

1–5 of 167